Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apolipoprotein E. Structure, function, and possible roles in Alzheimer's disease

R W Mahley1, B P Nathan, R E Pitas

  • 1Gladstone Institute of Cardiovascular Disease, San Francisco, California 94141-9100, USA.

Annals of the New York Academy of Sciences
|January 17, 1996
PubMed
Summary

Apolipoprotein E4 (apoE4) promotes Alzheimer's disease pathology by impairing neuronal growth and potentially enhancing plaque formation. Apolipoprotein E3 (apoE3) supports neuronal health, suggesting differential roles in neurodegenerative diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Apolipoprotein (apo) E4 and Alzheimer's disease: unique conformational and biophysical properties of apoE4 can modulate neuropathology.

Acta neurologica Scandinavica. Supplementum·2006
Same author

Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).

The pharmacogenomics journal·2006
Same author

An interaction between the TaqIB polymorphism of cholesterol ester transfer protein and smoking is associated with changes in plasma high-density lipoprotein cholesterol levels in Turks.

Clinical genetics·2005
Same author

Regionally specific modulation of brain apolipoprotein E in the mouse during the estrous cycle and by exogenous 17beta estradiol.

Experimental neurology·2003
Same author

DGAT1 promoter polymorphism associated with alterations in body mass index, high density lipoprotein levels and blood pressure in Turkish women.

Clinical genetics·2002
Same author

Plasma lipids in Turkish children: impact of puberty, socioeconomic status, and nutrition on plasma cholesterol and HDL.

Journal of lipid research·2001

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Apolipoprotein E (apoE) isoforms, particularly apoE4, are linked to Alzheimer's disease (AD) neuropathology, including amyloid plaques and neurofibrillary tangles.
  • The apoE4 isoform is a significant genetic risk factor for late-onset AD.
  • Understanding the differential effects of apoE isoforms on AD pathogenesis is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the differential effects of apolipoprotein E3 (apoE3) and apolipoprotein E4 (apoE4) on neuronal growth and cytoskeletal function in vitro.
  • To explore the potential mechanisms by which apoE isoforms influence amyloid beta (A beta) peptide aggregation and neurofibrillary tangle formation.

Main Methods:

  • In vitro incubation of apoE isoforms with amyloid beta (A beta) peptide to assess network formation.

Related Experiment Videos

  • Neuronal growth assays using peripheral and central nervous system neurons (dorsal root ganglia and Neuro-2a cells) with apoE3 and apoE4 in the presence of lipids.
  • Quantification of apoE isoform accumulation within neuronal cells.

    • Main Results:

    • ApoE4 formed denser, more stable networks with A beta peptide compared to apoE3 in vitro.
    • ApoE3 stimulated neurite extension and branching in neurons, while apoE4 inhibited these processes.
    • Neuroblastoma cells accumulated more apoE3 than apoE4, suggesting differential cellular uptake or processing.

    Conclusions:

    • Apolipoprotein E4 may impair neuronal growth and cytoskeletal function, contributing to Alzheimer's disease pathogenesis.
    • Differential interactions of apoE isoforms with A beta peptide and neuronal cells underlie their distinct roles in AD.
    • Targeting apoE isoform-specific pathways may offer therapeutic strategies for Alzheimer's disease.